Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer

Figure 7

The prognostic nomogram with clinicopathological characteristics and the IAG signature risk score was developed from the TCGA MIBC cohort. The nomogram could predict the 1-, 2-, and 3-year survival probability of MIBC patients.